Ascorbate for Sarcoma
This trial will enroll patients with metastatic sarcoma who have not responded to prior treatment.
- Soft Tissue Sarcoma
- Bone Cancer
- Bone Sarcoma
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are participants being actively recruited for this trial?
"Affirmative. Clinicaltrials.gov displays that the clinical trial, which was initially advertised on November 24th 2020, is currently inviting participants to join. The research requires 20 people from a single location."
Have investigators conducted any other experiments regarding Ascorbate?
"Currently, there are 493 Ascorbate-focused clinical trials with 141 Phase 3 experiments. Adelaide, South Australia houses numerous of these tests; however, other medical centres in a total of 25061 locations around the world are also running investigations into this compound's efficacy."
What is the total capacity of participants for this clinical experiment?
"Affirmative. Data on clinicaltrials.gov shows that this medical trial, which was initially published on November 24th 2020 is actively accepting candidates. The study requires 20 patients who are willing to visit one location for participation."